Table 4.
Low serum levels (below the LLN at least once) for IgG and IgM (safety analysis set).
Overall safety population (N = 1969) | Continuous ofatumumab group (n = 1292) | Newly switched ofatumumab group (n = 677) | |
---|---|---|---|
Low IgG, n (%) | |||
<5.65 g/L | 30 (1.5) | 22 (1.7) | 8 (1.2) |
Low IgM, n (%) | |||
<0.40 g/L | 454 (23.1) | 324 (25.1) | 130 (19.2) |
LLN for IgG = 5.65 g/L; LLN for IgM = 0.40 g/L. Ig: immunoglobulin; LLN: lower limit of normal.